Our peptide service platform has superior synthesis capabilities to support a wide variety of peptide types, including linear, cyclic, stapled and highly modified peptides, to meet the customized needs of different customers.
Through an innovative solid-liquid phase combination method, Yifan Biopharma can mass-produce high-purity, side-chain modified long chains and complex peptides, and has extensive practical experience in the field of complex peptide projects. In addition to core technical services, we also provide value-added services such as API analysis and CMC submission writing to fully help customers accelerate the market process of peptide drugs.
Yifan Biopharma is committed to helping biopharmaceutical companies accelerate the development and commercialization of peptide drugs through innovative technologies and professional services.